Cost-effectiveness evaluation of amphotericin B, amphotericin B liposomal, caspofungin and voriconazol in treating aspergillosis under the brazilian public health care system perspective.

Related Articles

Cost-effectiveness evaluation of amphotericin B, amphotericin B liposomal, caspofungin and voriconazol in treating aspergillosis under the brazilian public health care system perspective.

Value Health. 2013 May;16(3):A89

Authors: Fujii RK, Manfrin DF, G D A L, Hájek P, Mould J

PMID: 23694617 [PubMed - in process]

Deja un comentario

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.